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The breakdown of antibiotics by β-lactamases may be cooperative, since resistant cells can detoxify
their environment and facilitate the growth of susceptible neighbours. However, previous studies of
this phenomenon have used artificial bacterial vectors or engineered bacteria to increase the
secretion of β-lactamases from cells. Here, we investigated whether a broad-spectrum β-lactamase
gene carried by a naturally occurring plasmid (pCT) is cooperative under a range of conditions. In
ordinary batch culture on solid media, there was little or no evidence that resistant bacteria could
protect susceptible cells from ampicillin, although resistant colonies could locally detoxify this
growth medium. However, when susceptible cells were inoculated at high densities, late-appearing
phenotypically susceptible bacteria grew in the vicinity of resistant colonies. We infer that persisters,
cells that have survived antibiotics by undergoing a period of dormancy, founded these satellite
colonies. The number of persister colonies was positively correlated with the density of resistant
colonies and increased as antibiotic concentrations decreased. We argue that detoxification can be
cooperative under a limited range of conditions: if the toxins are bacteriostatic rather than
bacteridical; or if susceptible cells invade communities after resistant bacteria; or if dormancy allows
susceptible cells to avoid bactericides. Resistance and tolerance were previously thought to be
independent solutions for surviving antibiotics. Here, we show that these are interacting strategies:
the presence of bacteria adopting one solution can have substantial effects on the fitness of their
neighbours.
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A cooperative trait is a behaviour by one individual
that can benefit another (West et al., 2006). In
bacteria, cooperative traits often come in the form
of ‘public goods’ released into the environment and
available to all. Many virulence factors, including
siderophore production, Cry proteins and quorum-
regulated traits are cooperative (West and Buckling,
2003; Diggle et al., 2007; Sandoz et al., 2007;
Raymond et al., 2012; Zhou et al., 2014). Antibiotic
resistance conferred by the enzymatic breakdown of
drugs is potentially a cooperative trait as it can
detoxify the environment for all cells, and the
production of β-lactamases, which cleave and
deactivate penicillins, is often cited as a social trait
in bacteria (West et al., 2006; Diggle et al., 2007;
Brown et al., 2009). Clinical studies have suggested
that protective clearance is mediated by the release of
β-lactamase enzymes into the environment by produ-
cing cells (Brook, 2004), and packaging of β-lactamases
into extracellular vesicles has been demonstrated in
Pseudomonas aeruginosa (Ciofu et al., 2000). Secretion
of enzymes could increase the area of antibiotic
clearance, benefiting all cells in a local population.
The phenomenon of protective clearance of anti-
biotics by resistant cells is commonly seen by
microbiologists in the presence of ‘satellite’ colonies
on transformation plates (Figure 1a). These non-
resistant colonies are able to grow on ampicillin
plates where resistant colonies are already estab-
lished. A plausible hypothesis that explains this
phenomenon is that resistant transformants clear the
antibiotic from their immediate vicinity, creating an
antibiotic-free space where susceptible ‘satellite’
colonies can then grow. Previous studies have
demonstrated the survival of antibiotic-sensitive
Escherichia coli and Salmonella sp. in the presence
of resistant strains at high concentrations of anti-
biotic in vitro (Dugatkin et al., 2005; Clark et al.,
2009; Perlin et al., 2009). Cross-species protection of
susceptible bacteria by β-lactamase producers has
also been seen in vivo (Tacking, 1954; Hackman and
Wilkins, 1975; Brook et al., 1983), suggesting that the
benefits of β-lactamase enzymes may spread to entire
communities.
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Although social evolution theory has done much
to alter and improve modern microbial ecology,
there is some justification for being cautious about
claiming whether specific traits are cooperative or
not. A recent controversy has highlighted two
important points when studying cooperation: first,
we need to demonstrate that behaviours have real
fitness benefits for populations, and second that it is
desirable to study social evolution with realistic
models (Zhang, 2004; Ghoul et al., 2014), something
we have endeavoured to do in previous studies
(Raymond et al., 2012; Zhou et al., 2014). For
example, demonstrating that a microbial product is
secreted is not sufficient evidence for cooperation;
spatial structure, for example, can prevent secreted
products from being publicly available (Raymond
and Bonsall, 2013; Zhou et al., 2014), or metabolic
products may not be beneficial in all contexts (Zhang
and Rainey, 2013; Ghoul et al., 2014). Conversely,
secretion may not be necessary for cooperation in the
case of detoxification. Active removal of toxins and
the ensuing diffusion gradients or lowered concen-
tration of toxin may be all that is required to protect
susceptible bacteria (Lenski and Hattingh, 1986).
There are some grounds for being sceptical about
any claim that β-lactamases are generally coopera-
tive. Previous experiments have used model bacteria
with altered sites of expression and potentially
increased secretion (Dugatkin et al., 2005; Perlin
et al., 2009) and these data might not reflect social
interactions in more natural conditions. It is impor-
tant therefore to consider whether antibiotic
resistance genes in the more realistic context of
naturally-occurring plasmids can lead to cooperative
detoxification of antibiotics. An additional consid-
eration is whether the antibiotic in question is
bacteriostatic or bactericidal. When β-lactams are
bacteriostatic, that is, if they suspend growth but do
not rapidly kill bacteria, then the potential for social
interactions may be increased as susceptible bacteria
may survive until detoxification by neighbours can
reduce concentrations of antibiotics to below inhibi-
tory doses. However, β-lactam antibiotics can be
bactericidal, that is, rapidly lethal to bacteria, under
a range of conditions (Rolinson et al., 1977; Cozens
et al., 1986). Any bactericidal activity is expected to
substantially restrict the conditions for coexistence
and social exploitation to a narrow range that may
depend on initial dosage, as well as the frequency of
resistant and susceptible bacteria (Lenski and
Hattingh, 1986; Levin, 1988).
However, bacteria do have mechanisms that
enable them to escape or tolerate the effects of
bactericidal antibiotics, one being a ‘persister’ state
in which dormant cells can survive exposure to
antibiotics (Lewis, 2010). Persister cells were identi-
fied early in the clinical life of penicillin (Bigger,
1944), but a recent resurgence in interest has been
fuelled by a wider appreciation of their clinical
importance, especially in the light of the current
antibiotic resistance crisis (Lewis, 2007). Persister
cells are natural variants present at low frequency in
the bacterial population (Lewis, 2010). The pheno-
typic switch between persistence and active growth
appears to occur at random, although it is affected by
growth phase (Balaban, 2004). The presence of
persisters in biofilms is thought to contribute to
increased antimicrobial tolerance and the mainte-
nance of chronic infections (Brooun et al., 2000;
Lewis, 2001; Harrison et al., 2005). Since satellite
colonies on ampicillin plates are characterized by a
delayed growth pattern, appearing after 24–72 h of
cultures, and emerge as rare individuals from a high
density of bacteria, they have many of the character-
istics of cells that have passed through a persister
Figure 1 (a) Satellite colonies around a successful pUC19
transformant on ampicillin agar. Transformation of E. coli
DH10B with pUC19 confers resistance to ampicillin and also
restores the lac operon, resulting in a blue colony on agar
containing X-Gal and IPTG. The successful transformants
appeared after ~ 16 h, white susceptible colonies appeared after
424 h incubation and can be seen growing around the resistant
transformants. (b) Antibiotic clearance bioassay. Susceptible
colonies grow on ampicillin plates in the presence of resistant
colonies (bottom row), but not alone (top row). Resistant colonies
were incubated for 48 h on 100 μgml− 1 ampicillin plates before
the addition of susceptible colonies. Susceptible strains can grow
in the region around the resistant colony, but do not grow outside
the central zone or in the absence of a resistant colony (top row).
These assays were repeated seven times.
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state. We therefore hypothesised that phenotypically
susceptible bacteria might only rarely be able to
benefit from detoxification by others while persisters
may be more likely to exploit the β-lactamases of
their neighbours.
The primary aim of this work was to examine
cooperative β-lactam resistance using a naturally
occurring resistance plasmid, pCT, (Cottell et al.,
2011) and to investigate both the environmental and
demographic conditions under which cooperative
resistance occurs. In line with social evolution
theory, we expected that ‘cheating’ or exploitation
of detoxification by susceptible cells should increase
with the density and frequency of resistant bacteria
(Ross-Gillespie et al., 2007, 2009; Raymond et al.,
2012). To this end, competition experiments were
conducted between the pCT-carrying strain and an
otherwise isogenic plasmid-free E. coli under a
variety of conditions. The results of these experi-
ments showed little or no cooperative resistance, in
other words phenotypically susceptible bacteria did
not tend to have an increased ability to survive
antibiotics in the presence of resistant cells. We then
tested whether dormancy has a role in the ability of
E. coli to exploit the β-lactamase activity of
neighbouring cells.
Materials and methods
Strains and culture techniques
Our standard culture conditions used either 5ml
Luria Bertani (LB) broth (Fisher Scientific UK
Ltd., Loughborough, UK), or agar plates with
LB broth and 2% (w/v) agar (Agar Bacteriological
No. 1, Oxoid, Basingstoke, UK). Broth and plates
were supplemented with antibiotics as required; pCT
plasmid-carrying strains were maintained on plates
containing either ampicillin (100 μgml−1, sodium
salt, Sigma-Aldrich, Gillingham, UK) or cefotaxime
(8 μgml−1, sodium salt, Melford Laboratories,
Ipswich, UK).
Initial detoxification bioassays used E. coli DH10B
+pCT as the resistant strain, while all subsequent
competition experiments used E. coli K-12 MG1655.
We created readily distinguishable E. coli K-12
MG1655 by generating a lac null knockout mutant
via disruption of chromosomal lacZYA genes
(nucleotides 360 842–365 662). This produces a
Δlac mutant with a white phenotype in the presence
of X-Gal and IPTG, while wild-type bacteria are blue
on this media. Mutants were produced using the
Xercise protocol, as described by Bloor and
Cranenburgh (2006). Diagnostic PCR was used to
assess the insertion and subsequent deletion of the
dif-CAT-dif fragment into MG1655. Diagnostic PCR
was conducted using Taq (Qiagen, Manchester, UK)
with an annealing temperature of 55 °C and using the
primer F Lac diag (5′-ACGGAAAGAGTAACGTTG
GGTGC-3′) and R Lac diag (5′-GCGCCATTACC
GAGTCCGGG-3′). Deletion primers for MG1655
Δlac were taken from Datsenko and Wanner (2000).
The fitness cost of the lacZYA knockout was
assessed with competition on plates. We introduced
the resistance plasmid pCT in the wild-type E. coli
K-12 MG1655 via electroporation. The ΔlacZYA
MG1655 white mutant was used as our susceptible
strain.
Detoxification bioassay
A simple bioassay was used to assess whether
pCT-carrying bacteria were capable of clearing
β-lactam antibiotics from solid media. A single
resistant colony was streaked onto LB agar contain-
ing 100 μgml− 1 ampicillin and incubated at 37 °C for
48 h (Figure 1). Single colonies of susceptible E. coli
were then streaked from the central resistant colony
to the edge of the plates and onto plates with no
resistant colony (Figure 1). Plates were incubated at
37 °C overnight and growth measured from the
central colony outwards. In a further assay,
the central resistant colony was killed using a
chloroform soaked filter disk, applied to the central
colony for 10min and then removed and allowed to
dry before addition of the susceptible strain. Experi-
ments were repeated over a range of ampicillin
concentrations.
Competition experiments
Competition experiments were conducted on LB
agar plates containing X-Gal (0.02mgml− 1) and
IPTG (0.1 mM). We chose a range of antibiotic doses
that would bracket the minimal inhibitory concen-
trations of ampicillin in the susceptible bacteria
(4 μgml− 1) and cefotaxime (0.06 μgml− 1). OD600 of
overnight (16 h) cultures of competing strains
(susceptible and resistant) was measured and
cultures diluted to approximately equal cell density
with 0.85% (w/v) saline. Cultures were then mixed
at ratios of 1:10, 3:10, 50:50 and 9:10 of resistant to
susceptible cells and diluted with saline to give an
approximate cell density of 1 colony-forming unit
per μl (CFU μl−1). To confirm the initial ratio of cells,
mixed cultures were plated onto LB agar+X-Gal and
IPTG and incubated overnight at 37 °C, and blue and
white colonies counted. In all experiments, 100 μl
mixture or susceptible-only control was spread onto
plates and incubated at 37 °C for 72 h. Colonies were
then harvested by adding 5ml saline to the plate,
loosening colonies with a sterile spreader and
homogenising with a pipette. Harvested colonies
were serially diluted and plated onto LB agar+X-Gal
and IPTG, with and without ampicillin. Plates were
incubated at 37 °C overnight, and colonies counted
to determine final ratios and relative fitness of the
susceptible (MG1655 ΔlacZYA) strain. The overall
design of the competition experiments is set out in
Supplementary Figure S1. Three experiments were
conducted, in which we manipulated (i) the initial
proportion of resistant cells (approximately 0.1, 0.3
0.5, 0.9); (ii) the antibiotic (cefotaxime, rather than
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ampicillin) or (iii) the total density of bacteria
per plate.
Persister competition experiments
To increase numbers of persisters to detectable
levels, a large volume of susceptible culture was
used to inoculate competition plates. An 8-h starter
culture in 5ml LB broth was used to initiate 300ml
overnight culture by 1:1000 dilution. The overnight
culture was centrifuged at 4000 g for 10min, resus-
pended in 6ml 0.85% saline and diluted 1:10
(no dilution was used in the varying dose experi-
ment). Mixtures were made 50:50 with an overnight
culture of resistant cells. Initial counts and competi-
tion plates were set up as described above. After
24 h, competition plates were moved to room
temperature incubation (approximately 21 °C) for
up to 3 weeks. Blue and white colonies were counted
after 24 h, and then periodically. After 3 weeks,
incubation plates were photographed and potential
persister colonies screened. We defined persister
colonies as being composed of phenotypically
susceptible bacteria (that is, white) that appeared as
strong colonies after a period of no growth (24 h after
initial plating). We conducted two experiments that
varied in (i) the initial number of resistant colonies
per plate and (ii) the antibiotic dose.
We confirmed that late-appearing white colonies
were phenotypically antibiotic susceptible, and
therefore persisters, by picking a subset of colonies
onto LB agar with and without ampicillin (at 100
μgml− 1), and by minimum inhibitory concentration
(MIC) assays. We also tested whether putative
persisters had acquired the pCT plasmid by trans-
formation or conjugation by screening for the
presence of pCT using primers designed to amplify
the trbA plasmid-specific conjugation gene (FtrbA
diag 5′-CGGCATCCAGGCAGGCATCA-3′ and RtrbA
diag 5′-TTCAGCCCTGCCCGGTCATT-3′).
Data analysis
The relative fitness of susceptible cells in competi-
tion experiments was calculated as described by
Lenski (1988); also see Dahlberg and Chao (2003),
and is given by the equation:
Wrs ¼ log 2Ns finalð Þ=Ns initialð Þlog 2Nr finalð Þ=Nr initialð Þ
where Wrs is the fitness of strain s (susceptible)
relative to strain r (resistant) and N is the cell density
at the start and end of the experiment. Initial cell
density was derived from the mean susceptible and
resistant counts (CFU ml− 1) in the antibiotic-free
control plates in each experiment. It is not possible
to calculate relative fitness when there is no
detectable growth; therefore, all final cell counts
were transformed by addition of the minimal
detectable value, calculated as the ratio of the
minimum possible CFU count over the maximum
possible CFU count.
Relative fitness of susceptible bacteria and counts
of persister colonies were analysed using generalised
linear modelling, conducted in R v3.02 (R Core Team,
2013). Since the responses of bacterial fitness to
antibiotic were non-linear, we fitted log-transformed
concentrations as a factor rather than as a covariate.
Results
Detoxification bioassay demonstrates protective
clearance by resistant bacteria
This bioassay provides a clear visualisation of the
resistant strain’s ability to facilitate growth of
susceptible bacteria (Figure 1b, Supplementary
Figure S2). The sensitive DH10B strain only grows
on ampicillin plates in the region around the
resistant DH10B+ pCT colony, despite being inocu-
lated to the edges of the plate (bottom row), and does
not grow at all in the absence of resistant colonies
(top row). Similar results were obtained when the
central colonies were killed with chloroform,
indicating that susceptible growth is not due to some
interaction (such as conjugation) between resistant
and susceptible strains (data not shown). Further
experiments with E. coli K-12 MG1655 showed
that the extent of detoxification is dependent on
ampicillin dose (Supplementary Figure S2).
Fitness costs of plasmid carriage and of lacZ marker
We examined the relative fitness of susceptible
bacteria at low doses of antibiotic (0 and 4 μgml−1)
in all competition experiments in order to assess the
fitness burden of the carriage of pCT. This analysis
was complicated by the fact that both cell density and
frequency of plasmid carriage had significant effects
on fitness at these doses (density—F1,66 = 4.64,
P=0.035; frequency—F1,67 = 6.69, P=0.012). How-
ever, after taking these factors into account, the
relative fitness of susceptible cells was estimated at
1.06 (s.e. 0.020; 95% confidence limits, 1.028–1.099;
Figure 2a) for a ratio of 50:50 resistant and susceptible
cells, indicating a small but significant cost of plasmid
carriage. The fitness of susceptible bacteria decreased
significantly as we increased the dose of ampicillin to
4 μgml−1, a value below the MIC (post hoc test,
estimated difference=−0.03, t=−2.213, P=0.03;
Figure 2b). Preliminary experiments showed that
MG1655 has very slightly lower fitness on agar plates
than the white mutant MG1655 ΔlacZYA in the
absence of antibiotic (mean relative fitness: 0.978,
95% confidence limits: 0.96–0.99).
Relative fitness of susceptible bacteria across a range of
antibiotic doses and densities of resistant cells
In all competition experiments on ampicillin, the
relative fitness of susceptible bacteria declines
dramatically at inhibitory doses (32 and 100 μg-
ml− 1), with fitness values close to their minimum
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possible values in nearly all cases (Figure 2)
(F3,133 = 232, P≪0.0001). This result was highly
repeatable indicating that susceptible cells do not
typically benefit from the presence of resistant cells
at inhibitory doses of antibiotic, in contrast to the
results of the detoxification bioassay (Figure 1b). The
same pattern was observed in cefotaxime experi-
ments, since the presence of resistant bacteria never
allowed susceptible cells to survive and grow at
doses of 0.064 μgml−1 or above (data not shown).
In the susceptible-only single strain controls, there
was no growth in the presence of inhibitory ampi-
cillin doses. In a variant of this mixed strain assay in
which doses were increased incrementally between 4
and 30 μgml−1, growth of susceptible bacteria was
only seen at 4 μgml−1. We expected that an increased
initial proportion of resistant bacteria might increase
the fitness of susceptible bacteria, since more resistant
bacteria should translate to more rapid detoxification
of antibiotic. However, the initial proportion of
resistant cells did not significantly affect relative
fitness (F1,131 = 0.0159, P=0.90, Figure 2b) when we
considered fitness at low and high doses of antibiotic.
Similarly, we expected that susceptible bacteria
might be better able to survive when we increased
the initial densities of all bacteria on plates. Here,
we found that the density of colonies used to
inoculate each plate had a small positive effect on
relative fitness (F1,132 = 4.79, P=0.030, Figure 2c);
although this effect interacted with antibiotic dose
(F3,129 = 5.47, P=0.0014), and was weakest at 32
μgml−1 (post hoc t test, effect =− 5.28 ×10− 6,
s.e. = 1.5×10−6, t=−3.43, P=0.00083). Notably, some
isolated susceptible colonies were detected on plates
with 32 μgml−1 and 100 μgml−1 of antibiotic in the
presence of resistant bacteria, and this typically
occurred at higher densities. These isolated colonies
produced fitness values that are less than 1 but greater
than zero. Figure 2 shows that these phenotypically
susceptible bacteria were not consistently observed in
all replicates within a particular dose. However, these
data suggest that higher cell densities may facilitate
some susceptible survival at inhibitory antibiotic
doses, although this level of survival was low. An
additional analysis, which used a Poisson-based
model, and therefore could take into account the rare
occurrence of susceptible colonies indicated that
counts of susceptible colonies at inhibitory doses
significantly increased with the log of the number of
resistant bacteria at inoculation (F1,75 = 5.27, P=0.047,
glm with quasipoisson errors; counts were observed
after competition experiments were plated out at a
standard dilution of 10−6).
β-Lactam resistant bacteria facilitate growth of
persisters
Here, we tested the hypothesis that susceptible
bacteria can benefit more readily from the β-lactamase
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Figure 2 Relative fitness of susceptible bacteria in mixed populations at different antibiotic doses. (a) The fitness cost of plasmid carriage
in the absence of ampicillin and at a sub-inhibitory dose. (b) At varying initial proportions of resistant bacteria, proportions are indicated
in banners above panels. (c) At varying initial cell density on plates, where banner labels indicate CFUml−1. Relative fitness of susceptible
cells was calculated as described by Lenski (1988), a value of 41 indicates that susceptible bacteria higher relative fitness than the
resistant competitor, and a value of o1 indicates lower relative fitness. Points are raw data from n=5 replicates per treatment.
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activity of their neighbours by undergoing a period
of dormancy. In these experiments we used high
population densities of susceptible bacteria, in order
to increase the frequency of persisters to detectable
levels. We monitored bacterial populations on plates
for up to 3 weeks after initial exposure to antibiotics;
late-appearing white colonies were interpreted as
being founded by cells that had passed through a
period of dormancy. Our screens of a subset of white
putative persister colonies confirmed that they could
not grow at ampicillin doses of 100 μgml− 1; that
MICs were indistinguishable from our original
susceptible strain and we could not amplify pCT-
specific amplicons using the PCR.
At high concentrations of susceptibles (3.5 × 108),
late-appearing white susceptible colonies were
observed close to blue resistant colonies even at
the highest ampicillin dose, 100 μgml− 1 (Figure 3a).
At ampicillin doses of 100 μgml−1 these susceptible
colonies were not seen in the control plates in the
absence of resistant bacteria, confirming that this
ability to re-enter active growth was dependent on a
social interaction with their neighbours. Persister
colonies did appear on control plates at 32 μgml−1
when plates were incubated for 5 days at 21 °C.
The number of these susceptible persister colonies
increases with the number of resistant colonies
present (Figure 3b; R2 = 0.8384, F1,16 = 87.907,
Po0.0001) and over time, as shown by the highly
significant resistant colonies by time interaction term
(Figure 3c; F1,92 = 17.85, Po0.001). The number of
persister colonies decreased with increasing antibio-
tic dose (Figure 3d, F1,50 = 55.62, Po0.001), and this
experiment also shows a significant dose by resistant
colony interaction term (F1,50 = 6.780, P=0.0121). The
key effects of dose, and the linear relationship
between persisters and resistant cells, could be
repeated when experiments were conducted at 37 °C
(Supplementary Figure S3). All these data are
consistent with the hypothesis that resistant cells
are breaking down the antibiotic in their vicinity,
facilitating the successful breaking of dormancy by
phenotypically susceptible bacteria: resistant cells
and lower antibiotic concentrations will lead to a
more rapid reduction in antibiotic concentration and
higher survival rates as cells cease being dormant.
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Figure 3 The relationship between persisters and the presence of resistant colonies. (a) × 3.0 magnification image showing resistant
colonies (blue) and persister colonies (white) on LB agar 100 μgml− 1 ampicillin+X-Gal and IPTG. Resistant colonies appeared after
overnight incubation at 37 °C. Persister colonies appeared after a further 24 h of incubation. (b) The number of persister colonies increases
with the number of resistant colonies, data are numbers of persister and resistant colonies per plate after 8 days of incubation (both sqrt
transformed). R2 = 0.8384. (c) Persister colonies appear more rapidly on plates containing higher number of resistant colonies (n=6
replicates). (d) Higher numbers of persister colonies were observed at lower doses of ampicillin (n=6 replicates).
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Discussion
In this study, bacterial cells that are susceptible to
β-lactam antibiotics were only able to benefit from
the protective clearance of those antibiotics by
resistant cells under very specific conditions. We
posit that a sub-population of these susceptible cells
are ‘persisters’: natural variants present at low
frequency in the susceptible population, which
survive high antibiotic concentration by dormancy
(Lewis, 2010). Very high densities of susceptible
bacteria in these experiments increased the numbers
of persisters to a detectable level. Once the level of
antibiotic is sufficiently reduced by the resistant
cells, colonies founded by persister cells begin to
appear. This explains both the lag before suscep-
tibles appear, and the increase in numbers of
persisters over time, as they switch back to metabolic
activity at random (Balaban, 2004). Persister cells
survive the initial high concentration of antibiotic by
remaining dormant, but crucially their ability to
grow is a social trait as it is dependent on the
frequency and density of neighbouring β-lactamase
producers. Persistence, therefore, facilitates cheating
and the exploitation of antibiotic-free space provided
by the resistant cells.
The observation that there is no social benefit for
the susceptible strain except in the presence of
persisters contrasts with previous work demonstrat-
ing protective clearance of antibiotics by resistant
strains (Dugatkin et al., 2005; Clark et al., 2009;
Perlin et al., 2009; Yurtsev et al., 2013). One possible
explanation for this difference is that different strains
and experimental set-ups may produce altered
antibiotic tolerance. In these experiments, we show
that any dose above the MIC is bactericidal to all
growing E. coli. The bactericidal action of β-lactams
is known to be variable and dependent on the
specific drug, the strain, growth rate and stage, and
the nutrient availability (Hobby et al., 1942; Rolinson
et al., 1977; Cozens et al., 1986; Tuomanen et al.,
1986). For example, the bactericidal effect of cefo-
taxime is similar to that of other β-lactams; however,
cefotaxime has been shown to have remarkable
potency against Enterobacteriaceae and to be bacter-
icidal at doses at or close the MIC (Jones and
Thornsberry, 1982; Neu, 1982). It is therefore
possible that the experimental design of the earlier
papers facilitated susceptible tolerance of doses
above MIC, either through strain selection or through
some element of the growth conditions, producing a
bacteriostatic response to ampicillin rather than a
bactericidal effect. This tolerance effect has been
seen for mercury resistance, where a threshold exists
above which susceptible cells are inhibited but not
killed (Ellis et al., 2007).
Perhaps a more likely explanation is that the part-
batch, part-chemostat conditions used in these
previous studies facilitate more rapid and general-
ised clearance of antibiotic than the strict batch
culture method employed in this study. The model
used by Dugatkin et al. (2005) and Perlin et al. (2009)
allows build up of β-lactamases in one half of the
chamber, and periodically replenishes the antibiotic
in the other half. This build up of enzyme facilitates
rapid breakdown of the antibiotic, similar to the
earlier chemostat models in which coexistence
occurs only when susceptible cells are added to an
already established resistant culture (Lenski and
Hattingh, 1986; Lenski, 1988). In a subsequent
study, Dugatkin et al. recognise that enzyme
accumulation may be a contributory factor (Clark
et al., 2009). The homogenous broth culture envir-
onment may facilitate more rapid breakdown of
antibiotic simply by bringing more enzymes into
contact with their substrate, as the law of mass action
states. In addition, passive extracellular release of
β-lactamases from the Gram-negative periplasm or
‘leakage’ (Livermore, 1995) will have a greater
impact in broth culture than in the solid batch
culture environment. In this study, any exogenous
enzyme would diffuse slowly through the agar,
reinforcing the spatial structure of the environment,
rather than clearing substantially more antibiotic.
Both Clark et al. (2009) and Perlin et al. (2009) find
substantially more extracellular β-lactamase in
cultures where protective clearance is seen.
Dugatkin et al. (2005); Perlin et al. (2009) and
Clark et al. (2009) all draw a distinction between
‘self-limited’ and ‘shared’ resistance, based on the
localisation of the enzyme, enzymes in the shared
resistance system being localised to the outer
membrane. The results of this study question this
differentiation, as no modifications to pCT have been
made to alter the enzyme localisation, which is
naturally largely periplasmic (Livermore, 1995).
Yurtsev et al. (2013) point out that the site of
antibiotic action determines the degree to which
the resistant cells benefit from the public good, but
that this does not affect the overall resistant-
susceptible dynamic, which is determined by the
rate of degradation alone. More β-lactamase was
found in the supernatant of the ‘shared’ resistance
strain, due to breaking off of the enzyme from the
cells outer membrane (Clark et al., 2009), confirming
the ‘altruistic’ nature of resistance compared with
the ‘self’ resistance strain. However, this breaking off
from the cell appears to incur a fitness cost for the
‘shared’ resistance strain. This fact, coupled with
free β-lactamase increasing the rate of degradation,
could explain the survival of the susceptibles, rather
than the enzyme localisation.
In this study, the degradation of antibiotic in
culture was not fast enough to protect the majority of
antibiotic susceptible cells: there was a time-
lag before cooperative detoxification could be
exploited. This impact of history on exploitation
has implications for how we might theoretically
describe the social biology of detoxification. Detox-
ification is typically considered as a snowdrift game,
in which co-operators reap some direct benefit from
their actions but in which there is also some element
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of a shared indirect benefit (Doebeli and Hauert,
2005). In these games it is best to cooperate when all
your neighbours are defecting, and these interactions
can promote stable co-existence of co-operators and
defectors via negative frequency dependence
(Doebeli and Hauert, 2005; Brown and Taddei,
2007). A simple assumption of these models is that
the benefit of cooperation is a function of the frequency
of co-operators. These models have been extended to
incorporate historical effects, such as durable public
goods, in this case the benefits of cooperation depend
upon current and past abundance of cooperators
(Brown and Taddei, 2007). Previous models of β-
lactamase-based detoxification in broth have found that
the dynamics can be summarised in terms of the
concentration of antibiotics and the cell density
(Yurtsev et al., 2013). However, in order to describe
the historical effects in this system, theory would also
have to capture the density and mortality rate of
susceptible bacteria as well as the current and past
abundance of resistant cells.
The clinical implications of this work depend on
whether detoxification of β-lactams in hosts resem-
bles that in liquid media (widespread cheating) or on
solid media (limited cheating). Arguably, colonies on
solid agar are more akin to host-associated biofilms,
which are also likely to contain persisters (Stewart
and Franklin, 2008). In broth susceptible bacteria
have strong competitive interactions with resistant
cells leading to an equilibrium of 20–30% resistant
cells at doses of 100 μgml− 1 ampicillin (Yurtsev
et al., 2013). This is potentially good news for
resistance management if cheating means lactam
antibiotics only weakly select for resistance. How-
ever, since this cheating depends on the public
availability of β-lactamases there is a counter-
intuitive outcome that the use of β-lactamase
inhibitors can, at some doses, increase the frequency
of resistant cells by removing their public services
from extracellular space (Yurtsev et al., 2013). In
contrast, if β-lactamase detoxification in hosts is like
that in solid media, then selection for resistance will
be more straightforward, with only a very small
fraction of persistent susceptible cells being able to
survive antibiotic therapy. Effective therapeutic
control of persisters is an ongoing challenge, but
complex communities of bacteria with a mixture of
tolerance and resistance strategies may require
complex treatment with combination therapy. Com-
binations have the advantage of reducing the prob-
ability of bacteria of spontaneous mutations to
multiple drugs (Worthington and Melander, 2013),
but also, as in the treatment of tuberculosis, enable
the control of bacteria with different growth rates,
physiologies and susceptibilities (Mitchison, 1985).
Theory, and this work, suggests that the conditions
for the coexistence of antibiotic resistant and
susceptible bacteria are quite narrow: the initial
antibiotic concentration must not exceed the lethal
dose, and the rates of degradation and antibiotic
influx must not allow the dose to increase (Lenski
and Hattingh, 1986). Experiments with mercury
resistance confirm that frequency-dependent
coexistence of resistant and susceptible genotypes
is strongly dose dependent (Ellis et al., 2007). In this
study, using batch culture, no dose greater than the
MIC could be found that consistently allowed the
coexistence of resistant and susceptible bacteria,
unless the susceptibles made the phenotypic switch
to persistence or resistant bacteria detoxified media
before colonisation by a susceptible strain.
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